Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2425-2430

  Geng, Yu ^a   Valbracht, Jean ^a   Lotz, Martin ^a,b  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

cartilage; chondrocytes; Interleukin 1; MAP kinase

Indexed keywords

CALCIUM IONOPHORE; CYCLIC AMP; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; SYNAPTOPHYSIN;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUALITATIVE DIAGNOSIS; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0029829536     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119056     Document Type: Article

References (56)

1. Vincenti, M.P., C.I. Coon, O. Lee, and C.E. Brinckerhoff. 1994. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Res. 22:4818-4827.
2. Goldring, M.B., J.R. Birkhead, L.F. Suen, R. Yamin, S. Mizuno, J. Glowacki, J.L. Arbiser, and J.F. Apperley. 1994. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94:2307-2316.
3. Harvey, A.K., S.T. Stack, and S. Chandrasekhar. 1993. Differential modulation of degradative and repair responses of interleukin-1-treated chondrocytes by platelet-derived growth factor. Biochem. J. 292:129-136.
4. Chandrasekhar, S., A.K. Harvey, and S.T. Stack. 1993. Degradative and repair responses of cartilage to cytokines and growth factors occur via distinct pathways. Agents Actions Suppl. 39:121-125.
5. Arner, E.C., and M.A. Pratta. 1991. Modulation of interleukin-1-induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C. Arthritis Rheum. 34:1006-1013.
6. Guerne, P.A., A. Sublet, and M. Lotz. 1994. Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts. J. Cell. Physiol. 158:476-484.
7. Hauselmann, H.J., L. Oppliger, B.A. Michel, M. Stefanovic-Racic, and C.H. Evans. 1994. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett. 352:361-364.
8. Blanco, F., and M. Lotz. 1995. IL-1 induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp. Cell. Res. 218:319-325.
9. Lotz, M., F.J. Blanco, J. von Kempis, J. Dudler, R. Maier, P. Villiger, and Y. Geng. 1995. Cytokine regulation of chondrocyte functions. J. Rheumatol. 22 (s43):104-108.
10. Pettipher, E.R., G.A. Higgs, and B. Henderson. 1986. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA. 83:8749-8753.
11. Chandrasekhar, S., A.K. Harvey, P.S. Hrubey, and A.M. Bendele. 1990. Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin. Immunol. Immunopathol. 55:382-400.
12. van de Loo, A.A., and W.B. van den Berg. 1990. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann. Rheum. Dis. 49:238-245.
13. O'Byrne, E.M., V. Blancuzzi, D.E. Wilson, M. Wong, and A.Y. Jeng. 1990. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum. 33:1023-1028.
14. Beasley, D., and M. McGuiggin. 1994. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J. Exp. Med. 179:71-80.
15. Beasley, D., J.H. Schwartz, and B.M. Brenner. 1991. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:602-608.
16. Beasley, D. 1990. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am. J. Physiol. 259:R38-R44.
17. Gronich, J., M. Konieczkowski, M.H. Gelb, R.A. Nemenoff, and J.R. Sedor. 1994. Interleukin 1 alpha causes rapid activation of cytosolic phospholipasec A2 by phosphorylation in rat mesangial cells. J. Clin. Invest. 93:1224-1233.
18. Crofford, L.J., R.L. Wilder, A.P. Ristimaki, H. Sano, E.F. Remmers, H.R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Invest. 93:1095-1101.
19. Hulkower, K.I., H.I. Georgescu, and C.H. Evans. 1991. Evidence that responses of articular chondrocytes to interleukin-1 and basic fibroblast growth factor are not mediated by protein kinase C. Biochem. J. 276:157-162.
20. Hulkower, K.I., and C.H. Evans. 1991. Protein phosphorylation and metalloproteinase synthesis by lapine articular chondrocytes. J. Rheumatol. Suppl. 27:110-113.
21. Hulkower, K.I., H.I. Georgescu, and C.H. Evans. 1989. Protein kinase C and chondrocyte activation. Agents Actions. 27:442-444.
22. Conquer, J.A., R.A. Kandel, and T.F. Cruz. 1992. Interleukin 1 and phorbol 12-myristate 13-acetate induce collagenase and PGE2 production through a PKC-independent mechanism in chondrocytes. Biochim. Biophys. Acta. 1134:1-6.
23. Mitchell, P.G., and H.S. Cheung. 1993. Protein kinase regulation of tumor necrosis factor alpha stimulated collagenase and stromelysin message levels in chondrocytes. Biochem. Biophys. Res. Commun. 196:1133-1142.
24. Ogata, Y., M.A. Pratta, H. Nagase, and E.C. Arner. 1992. Matrix metalloproteinase 9 (92-kD gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin I beta and a protein kinase C activator. Exp. Cell. Res. 201:245-249.
25. Mathias, S., A. Younes, C.C. Kan, I. Orlow, C. Joseph, and R.N. Kolesnick. 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science (Wash. DC). 259:519-522.
26. Kolesnick, R., and D.W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:325-328.
27. Munoz, E., A. Zubiaga, C. Huang, and B.T. Huber. 1992. Interleukin-1 induces protein tyrosine phosphorylation in T cells. Eur. J. Immunol. 22:1391-1396.
28. Cruz, T.F., G. Mills, K.P. Pritzker, and R.A. Kandel. 1990. Inverse correlation between tyrosine phosphorylation and collagenase production in chondrocytes. Biochem. J. 269:717-721.
29. Grima, D.T., R.A. Kandel, B. Pepinsky, and T.F. Cruz. 1994. Lipocortin 2 (annexin 2) is a major substrate for constitutive tyrosine kinase activity in chondrocytes. Biochemistry. 33:2921-2926.
30. Geng, Y., R. Maier, and M. Lotz. 1995. Tyrosine kinases are involved with the expression of inducible nitric oxide synthase in human articular chondrocytes. J. Cell. Physiol. 163:545-554.
31. Geng, Y., F.J. Blanco, M. Cornelisson, and M. Lotz. 1995. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J. Immunol. 155:796-801.
32. Han, J., J.D. Lee, L. Bibbs, and R.J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science (Wash. DC). 265:808-811.
33. Derijard, B., M. Hibi, I.H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R.J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1025-1037.
34. Freshney, N.W., L. Rawlinson, F. Guesdon, E. Jones, S. Cowley, J. Hsuan, and J. Saklatvala. 1994. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 78:1039-1049.
35. Karin, M. 1994. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6: 415-424.
36. Davis, R.J. 1994. MAP kinases. Trends Biochem. Sci. 19:470.
37. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
38. Kallunki, T., B. Su, I. Tsigelny, H.K. Sluss, B. Derijard, G. Moore, R. Davis, and M. Karin. 1994. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8:2996-3007.
39. Kyriakis, J.M., P. Banerjee, E. Nikolakaki, T. Dai, E.A. Rubie, M.F. Ahmad, J. Avruch, and J.R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.). 369:156-160.
40. Lee, J.C., J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty, M.J. Blumenthal, J.R. Heys, S.W. Landvatter et al., 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (Lond.). 372:739-746.
41. Villiger, P.M., and M. Lotz. 1992. Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO (Eur. Mol. Biol. Organ.) J 11:135-143.
42. Geng, Y., and M. Lotz. 1995. Increased intracellular calcium selectively suppresses IL-1 induced NO production by reducing iNOS mRNA stability. J. Cell Biol. 129:1651-1657.
43. Livingstone, C., G. Patel, and N. Jones. 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO (Eur. Mol. Biol. Organ.) J. 14:1785-1797.
44. Schwarz, H., J. Tuckwell, and M. Lotz. 1993. A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. Gene. 134:295-298.
45. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R.J. Davis, G.L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (Wash. DC). 266:1719-1723.
46. Lotz, M., and P.A. Guerne. 1991. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 266:2017-2020.
47. Goldring, M.B., K. Fukuo, J.R. Birkhead, E. Dudek, and L.J. Sandell. 1994. Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J. Cell. Biochem. 54: 85-99.
48. Andrews, H.J., R.A. Bunning, T.A. Plumpton, I.M. Clark, R.G. Russell, and T.E. Cawston. 1990. Inhibition of interleukin-1-induced collagenase production in human articular chondrocytes in vitro by recombinant human interferon-gamma. Arthritis Rheum. 33:1733-1738.
49. Derjard, B., J. Raingeaud, T. Barrett, I.H. Wu, J. Han, R.J. Ulevitch, and R.J. Davis. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science (Wash. DC). 267:682-685.
50. Marshall, C.J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:179-185.
51. Aronheim, A., D. Engelberg, N. Li, N. al-Alawi, J. Schlessinger, and M. Karin. 1994. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell. 78:949-961.
52. Buday, L., and J. Downward. 1993. Epidermal growth factor regulates p21ras through the formation of a complex of receptor. Grb2 adapter protein, and Sos nucleotide exchange factor. Cell. 73:611-620.
53. Leevers, S.J., H.F. Paterson, and C.J. Marshall. 1994. Requirement for Ras in Rat activation is overcome by targeting Raf to the plasma membrane. Nature (Lond). 369:411-414.
54. Stokoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science (Wash. DC). 264:1463-1467.
55. Cobb, M.H., and E.J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846.
56. Minden, A., A. Lin, F.X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 81:1147-1157.